Studies related to Symptoms of Schizophrenia and Chromium

Lack Of Effect Of Chromium Supplementation On Mental State And Body Weight In People With Schizophrenia

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 20
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Average
Notes for this study:
The addition of 400 µg chromium (as picolinate) to antipsycotic therapy in a small sample of schizophrenic persons over three months failed to significantly influence symptoms of schizophrenia relative to control as assessed by PANSS and HAM-D rating scales.